Esta web utiliza cookies técnicas, de personalización y de análisis, propias y de terceros, para anónimamente facilitarle la navegación y analizar estadísticas del uso de la web. Obtener más información
Resultados de búsqueda
-
Mobile Broadband and the Telecommunications Industry in 2011
Applegate, Lynda M.; Herman, Kerry; Snively, ChristineCaso HBS-814009-EIniciativa emprendedoraMobile broadband carriers provide network access to the Internet for a range of devices (typically portable or mobile), including consumer devices such as smartphones, tablets and E-Readers, but also a host of new emerging devices. Mobile broadband networks enable data to travel in packets over telecommunication (telecom) companies' wireless (or cellular) networks. The number of worldwide mobile cellular subscriptions reached 6 billion in 2011, r...Desde 8,20 €
-
AEEC: Becoming an Innovation Catalyst, Teaching Plan
Applegate, Lynda M.; Weber, James; Mehta, SarahNota del Instructor HBS-318107-EThis teaching plan pairs with the case, "AEEC: Becoming an Innovation Catalyst" (case no. 317011).Desde 0,00 €
-
Tesla in 2015, Teaching Plan
Applegate, Lynda M.; Hull, Olivia; Mehta, SarahNota del Instructor HBS-818009-EIniciativa emprendedoraTeaching plan for case "Tesla in 2015" (HBS case no. 817081)Desde 0,00 €
-
AEEC: Becoming an Innovation Catalyst
Applegate, Lynda M.; Weber, James; Mehta, SarahCaso HBS-317011-EDesde 8,20 €
-
Applying Data Science and Analytics at P&G
Datar, Srikant M.; Mehta, Sarah; Hamilton, PaulCaso HBS-121006-ETecnologías de la informaciónSet in December 2019, this case explores how P&G has applied data science and analytics to cut costs and improve outcomes across its business units. The case provides an overview of P&G's approach to data management and governance, and reviews the challenDesde 8,20 €
-
Fitbit
Herzlinger, Regina E.; Snively, Christine; Mehta, SarahCaso HBS-317007-EConocimiento y comunicaciónIn 2019, Fitbit lost its leadership in the wearable sensor market to Apple and to cheaper alternatives. Why did it lose its market position? How will the proposed acquisition affect it and Google?Desde 8,20 €
-
NYC311
Kontokosta, Constantine E.; Weiss, Mitchell B.; Snively, Christine; Gulick, SarahCaso HBS-818056-EIniciativa emprendedoraJoe Morrisroe, executive director for NYC311, had some gut instincts but no definitive answer to the question he was just asked by one of the Mayor's deputies: "Are some communities being underserved by 311? How do we know we are hearing from the right people?" Founded in 2003 as a phone number for residents to dial (311) from a landline for information on city services and to log complaints, the city launched a 311 website and mobile app in 2009...Desde 8,20 €
-
MIA: Profit at the Base of the Pyramid
Applegate, Lynda M.; Davila Castilla, Jose Antonio; Mehta, Sarah; Sesia, AldoCaso HBS-817073-EIn January 2016, Guillermo Jaime had just returned home to Mexico City after attending a Harvard Business School executive education program. Jaime was the founder and CEO of Mejoramiento Integral Asistido (MIA), a company providing affordable housing to low-income Mexicans living at the base of the pyramid (BOP), defined as those living on less than $10 per day. Since its launch in 2009, MIA had built nearly 25,000 homes-which provided safe shel...Desde 8,20 €
-
JUUL and the Vaping Revolution
Toffel, Michael W.; Masko, John; Mehta, SarahCaso HBS-619006-EÉtica empresarial y Responsabilidad Social CorporativaIn the summer of 2018, San Francisco-based electronic cigarette (e-cigarette) maker JUUL Labs, was experiencing exponential growth. Sales of its JUUL e-cigarette had increased by 783% over the preceding year, projected revenues for 2018 topped $940 million, and the company had captured over 72% of the U.S. e-cigarette market. The company's success had thrust it into the spotlight, and JUUL Labs found itself at the center of considerable controver...Desde 8,20 €
-
Adaptive Platform Trials: The Clinical Trial of the Future
Stern, Ariel D.; Mehta, SarahCaso HBS-618025-EServicios y operacionesIn July 2017, Dr. Brian M. Alexander, president and CEO of the AGILE Research Foundation, was preparing to launch a new type of clinical trial-an adaptive platform trial-to study potential therapies for glioblastoma (GBM), an aggressive form of brain cancer. Alexander believed that the standard way in which new cancer drugs were tested-the traditional randomized controlled trial (RCT)-was limited in many ways. While statistically rigorous and s...Desde 8,20 €